Clinical Trials for Foundation Medicine

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins

Molecular Studies and Clinical Correlations in Human Prostatic Disease